Close Menu

NEW YORK (GenomeWeb News) – Verdezyne has received a $1.7 million grant from the National Institute of Allergy and Infectious Diseases that it will use to develop gene libraries for synthetic biology applications in its fermentation development program, the company said today.

The company, which formerly went by the name Coda Genomics, will use the Small Business Technology Transfer grant to fund development of bioinformatics applications for use in its mutant library and synthetic biology programs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Three US lawmakers call on the Trump Administration to end its program to collect DNA from detained migrants, the Hill reports.

Researchers in the US have developed a promising candidate vaccine against African swine fever, according to Bloomberg News.

Soccer players who head the ball a lot and who have a certain APOE allele may be more likely to have memory problems, according to HealthDay.

In Cell this week: a quantitative proteomic atlas based on the Cancer Cell Line Encyclopedia, gene regulation and differentiation in Toxoplasma gondii, and more.